Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX)
0.2925
+0.0809 (38.23%)
NASDAQ · Last Trade: Apr 3rd, 3:10 AM EDT
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · April 2, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · April 2, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025

Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · February 27, 2025

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 27, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · January 30, 2025

Via Benzinga · January 23, 2025

Via Benzinga · December 30, 2024

Via Benzinga · December 20, 2024

Via Benzinga · December 4, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 16, 2024

Via Benzinga · September 10, 2024

QNRX stock results show that Quoin Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 8, 2024

Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!
Via InvestorPlace · July 23, 2024

QNRX stock results show that Quoin Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 9, 2024